2021 Form 10-K Financial Statement
#000149315222008546 Filed on March 31, 2022
Income Statement
Concept | 2021 | 2020 Q4 | 2020 |
---|---|---|---|
Revenue | $0.00 | ||
YoY Change | |||
Cost Of Revenue | $0.00 | ||
YoY Change | |||
Gross Profit | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $21.46M | $1.320M | $4.320M |
YoY Change | 396.67% | 91.3% | 27.06% |
% of Gross Profit | |||
Research & Development | $6.745M | $1.820M | $7.960M |
YoY Change | -15.26% | ||
% of Gross Profit | |||
Depreciation & Amortization | $0.00 | $0.00 | $30.00K |
YoY Change | -100.0% | -100.0% | -57.14% |
% of Gross Profit | |||
Operating Expenses | $28.81M | $3.150M | $12.28M |
YoY Change | 134.61% | 356.52% | 262.24% |
Operating Profit | -$28.81M | -$3.150M | -$12.28M |
YoY Change | 134.61% | 356.52% | 262.24% |
Interest Expense | $5.710K | $40.00K | $170.0K |
YoY Change | -96.64% | 100.0% | 70.0% |
% of Operating Profit | |||
Other Income/Expense, Net | -$1.079M | ||
YoY Change | |||
Pretax Income | -$29.89M | -$3.110M | -$12.15M |
YoY Change | 146.0% | 357.35% | 259.47% |
Income Tax | $0.00 | ||
% Of Pretax Income | |||
Net Earnings | -$29.89M | -$3.290M | -$17.58M |
YoY Change | 70.02% | 145.52% | 351.93% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | -$0.85 | ||
Diluted Earnings Per Share | -$853.6K | -$503.1K | -$4.980M |
COMMON SHARES | |||
Basic Shares Outstanding | 35.02M shares | ||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2021 | 2020 Q4 | 2020 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $11.56M | $35.34M | $35.34M |
YoY Change | -67.29% | 265.08% | 265.08% |
Cash & Equivalents | $556.0K | $148.3K | |
Short-Term Investments | $11.00M | $16.72M | $16.72M |
Other Short-Term Assets | $1.106M | $300.0K | $300.0K |
YoY Change | 268.78% | -23.08% | -23.08% |
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $12.67M | $36.84M | $36.84M |
YoY Change | -65.62% | 257.32% | 257.32% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $149.0K | ||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | $1.500M | ||
YoY Change | |||
Other Assets | $0.00 | $0.00 | |
YoY Change | -100.0% | -100.0% | |
Total Long-Term Assets | $12.15M | $0.00 | $0.00 |
YoY Change | -100.0% | -100.0% | |
TOTAL ASSETS | |||
Total Short-Term Assets | $12.67M | $36.84M | $36.84M |
Total Long-Term Assets | $12.15M | $0.00 | $0.00 |
Total Assets | $24.81M | $36.84M | $36.84M |
YoY Change | -32.65% | 238.6% | 238.6% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $867.5K | $2.200M | $2.200M |
YoY Change | -60.57% | 233.33% | 233.33% |
Accrued Expenses | $172.4K | ||
YoY Change | |||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $0.00 | ||
YoY Change | |||
Total Short-Term Liabilities | $1.040M | $2.260M | $2.260M |
YoY Change | -53.99% | 47.71% | 47.71% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $125.9K | ||
YoY Change | |||
Total Long-Term Liabilities | $125.9K | $0.00 | $0.00 |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $1.040M | $2.260M | $2.260M |
Total Long-Term Liabilities | $125.9K | $0.00 | $0.00 |
Total Liabilities | $1.166M | $2.260M | $2.260M |
YoY Change | -48.42% | 47.71% | 47.71% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | |||
YoY Change | |||
Common Stock | |||
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $23.65M | -$5.257M | $34.58M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $24.81M | $36.84M | $36.84M |
YoY Change | -32.65% | 238.6% | 238.6% |
Cashflow Statement
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2021 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
USD | |
CY2021 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
USD | |
CY2020 | us-gaap |
Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
|
USD | |
CY2020 | us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
USD | |
CY2020 | MYMD |
Gain On Debt Forgiveness
GainOnDebtForgiveness
|
USD | |
CY2020 | MYMD |
Uninsured Casualty Losses
UninsuredCasualtyLosses
|
USD | |
CY2021 | MYMD |
Issuance Of Postmerger Common Shares At Exchange Ratio Per Premerger Common Share
IssuanceOfPostmergerCommonSharesAtExchangeRatioPerPremergerCommonShare
|
USD | |
CY2021 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
USD | |
CY2020Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
USD | |
CY2020Q4 | us-gaap |
Goodwill
Goodwill
|
USD | |
CY2020Q4 | us-gaap |
Long Term Investments
LongTermInvestments
|
USD | |
CY2021Q4 | us-gaap |
Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
|
USD | |
CY2021Q4 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
USD | |
CY2020Q4 | MYMD |
Due To Shareholders Non Current
DueToShareholdersNonCurrent
|
USD | |
CY2021Q4 | us-gaap |
Long Term Line Of Credit
LongTermLineOfCredit
|
USD | |
CY2021Q4 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
USD | |
CY2021Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
USD | |
CY2021 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
USD | |
CY2020 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
USD | |
CY2021 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
USD | |
CY2020 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
USD | |
CY2021 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
USD | |
CY2020 | us-gaap |
Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
|
USD | |
CY2020 | MYMD |
Marketable Securities Unrealized Loss
MarketableSecuritiesUnrealizedLoss
|
USD | |
CY2020 | MYMD |
Gain On Forgiveness Of Debt
GainOnForgivenessOfDebt
|
USD | |
CY2021 | MYMD |
Common Stock Options
CommonStockOptions
|
USD | |
CY2020 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
USD | |
CY2020 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
USD | |
CY2020 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
USD | |
CY2020 | us-gaap |
Cash Acquired From Acquisition
CashAcquiredFromAcquisition
|
USD | |
CY2020 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
USD | |
CY2020 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
USD | |
CY2021 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
USD | |
CY2021 | us-gaap |
Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
|
USD | |
CY2020 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
USD | |
CY2020 | us-gaap |
Interest Paid Net
InterestPaidNet
|
USD | |
CY2021 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
USD | |
CY2020 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
USD | |
CY2021 | us-gaap |
Stock Issued1
StockIssued1
|
USD | |
CY2020 | MYMD |
Other Asset Investment
OtherAssetInvestment
|
USD | |
CY2020 | us-gaap |
Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
|
USD | |
CY2020 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
USD | |
CY2020Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
USD | |
CY2021Q4 | us-gaap |
Accounts Payable Related Parties Current And Noncurrent
AccountsPayableRelatedPartiesCurrentAndNoncurrent
|
USD | |
CY2021Q4 | us-gaap |
Accounts Payable Other Current
AccountsPayableOtherCurrent
|
USD | |
CY2021Q4 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
USD | |
CY2021Q4 | MYMD |
Interest Payable Related Party
InterestPayableRelatedParty
|
USD | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
shares | |
CY2021 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
||
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
||
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
shares | |
CY2021 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
||
CY2021 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
|
||
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
shares | |
CY2021 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
||
CY2021 | MYMD |
Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled Or Expired In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrExpiredInPeriodWeightedAverageGrantDateFairValue
|
||
CY2021 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
USD | |
CY2020 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
USD | |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
USD | |
CY2020 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
USD | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
USD | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
USD |